Study reveals cardiovascular health could be biggest risk factor for dementia
Dementias, including Alzheimer’s disease, are estimated to affect 944,000 people in the UK
Read More
Tag: NICE Three School’s Dementia Research Programme
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
